Bothell, Washington
United States
35
2020-02-27
21
2020-06-30
These are the the leading inventors for applications assigned to ICOS Corporation:
ICOS Corporation based in Bothell, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Inhibitors of human phosphatidylinositol 3-kinase delta
#2 | 2020-01-16 ✅ Patent 10,906,907 granted on 2021-02-02Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
#3 | 2018-12-20 ✅ Patent 10,398,695 granted on 2019-09-03Inhibitors of human phosphatidylinositol 3-kinase delta
#4 | 2012-07-05 ✅ Patent 8,637,533 granted on 2014-01-28Inhibitors of human phosphatidylinositol 3-kinase delta
#5 | 2012-05-31 ✅ Patent 8,653,077 granted on 2014-02-18Inhibitors of human phosphatidylinositol 3-kinase delta
#6 | 2012-01-19QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
#7 | 2010-10-07 ✅ Patent 8,207,153 granted on 2012-06-26Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
#8 | 2010-01-28 ✅ Patent 8,455,471 granted on 2013-06-04Compositions of CHK1 inhibitors and cyclodextrin
#9 | 2008-12-25Compounds Useful for Inhibiting Chk1
#10 | 2008-11-27Recombinant method for making multimeric proteins
#11 | 2008-11-06 ✅ Patent 7,932,260 granted on 2011-04-26Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
#12 | 2008-09-25Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them
#13 | 2008-09-04 ✅ Patent 7,560,462 granted on 2009-07-14Compounds useful for inhibiting CHK1
#14 | 2007-11-29Method of Preparing a Ring Compound Having Two Adjacent Chiral Centers
#15 | 2007-11-08Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
#16 | 2007-08-09Use of chk1 inhibitors to control cell proliferation
#17 | 2007-04-26Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrin
#18 | 2007-02-20 ✅ Patent 7,179,912 granted on 2007-02-20Materials and methods to potentiate cancer treatment
#19 | 2006-12-14Novel human beta-2 integrin alpha subunit
#20 | 2006-09-28cGMP-binding, cGMP-specific phosphodiesterase materials and methods
#21 | 2006-08-08 ✅ Patent 7,087,634 granted on 2006-08-08Cyclic AMP-specific phosphodiesterase inhibitors
#22 | 2006-06-08Recombinant method for making multimeric proteins
#23 | 2006-05-18Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
#24 | 2006-04-06 ✅ Patent 7,176,229 granted on 2007-02-13Cyclic AMP-specific phosphodiesterase inhibitors
#25 | 2006-03-28 ✅ Patent 7,018,627 granted on 2006-03-28Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
#26 | 2006-03-16Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances and uses thereof
#27 | 2006-02-14 ✅ Patent 6,998,416 granted on 2006-02-14Cyclic AMP-specific phosphodiesterase inhibitors
#28 | 2006-01-24 ✅ Patent 6,989,260 granted on 2006-01-24Human poly(ADP-ribose) polymerase 2 materials and methods
#29 | 2005-11-24 ✅ Patent 8,138,195 granted on 2012-03-20Inhibitors of human phosphatidylinositol 3-kinase delta
#30 | 2005-11-24 ✅ Patent 7,662,548 granted on 2010-02-16Method of screening for modulators of HIV infection
#31 | 2005-11-03 ✅ Patent 7,608,618 granted on 2009-10-27Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
#32 | 2005-10-27Therapeutic uses for MDC and MDC antagonists
#33 | 2005-09-27 ✅ Patent 6,949,535 granted on 2005-09-27Inhibitors of human phosphatidyl-inositol 3-kinase delta
#34 | 2005-08-02 ✅ Patent 6,924,284 granted on 2005-08-02PARP inhibitors
#35 | 2005-03-08 ✅ Patent 6,864,070 granted on 2005-03-08Phosphodiesterase 10
174528 ⎘